RxDoctor Payments DataLook up a doctor →

LUMOXITI: payments to doctors

Payments that named LUMOXITI as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$341K
Providers
214
Transactions
261
Average per transaction
$1,308

The per-transaction average — $1,308 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 214 providers the average total is $1,596, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
AstraZeneca$244,80471.7%
Innate Pharma, Inc$72,35021.2%
Astrazeneca UK Limited$24,3047.1%
← All drugs & devices